VISION    ·    EXCELLENCE    ·    INCLUSIVENESS    ·    ADVOCACY    ·    SERVICE    ·    DEDICATION
Stay Connected

NP Week FREE REMS CE – Evidence-based Pain Management: Addressing the Growing Role of Nurse Practitioners and Physician Assistants in Managing Patients with Acute and Chronic Pain

Webinar/Online

Tuesday, November 10, 2020 at 1:00pm MT - 4:15pm MT
This event has ended.

Info

Topic

3 CE of REMS Compliant education. This CME activity, “Evidence-based Pain Management: Addressing the Growing Role of Nurse Practitioners and Physician Assistants in Managing Patients with Acute and Chronic Pain,” will help community NPs and PAs use pain-assessment tools to evaluate patients, improve their familiarity with the FDA Blueprint guidelines for treatment selection, and understand when to use non-opioid pharmacotherapies for neuropathic pain. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.

Speaker(s)

Christopher Gharibo, MD and Susan Pendergrass, FNP-BC. Jointly provided by USF Health and Rockpointe in collaboration with the National Council for Behavioral Health though a grant

Credits Offered

This event offers 3.0 contact hours to attendees (1.0 pharmacology) .
Accreditation Info: AANP.

Attachments

Additional Information

Join us during NP Week for a free REMS CME program which will satisfy the Utah DOPL annual requirement for prescribing.

The Utah Nurse Practitioners cordially invites you to attend a CME/CE-certified live webinar entitled, Evidence-based Pain Management: Addressing the Growing Role of Nurse Practitioners and Physician Assistants in Managing Patients with Acute and Chronic Pain, held live online!  This activity will will help community NPs and PAs use pain-assessment tools to evaluate patients, improve their familiarity with the FDA Blueprint guidelines for treatment selection, and understand when to use non-opioid pharmacotherapies for neuropathic pain. This activity is intended for clinicians involved in direct patient care, including HCPs who are registered with the DEA and eligible to prescribe all opioid analgesics.

Date:                Tuesday, November 10, 2020

Time:                1:00 – 4:15 PM MOUNTAIN

Location:         Live Online!

For full accreditation information and to register, visit: www.rockpointe.com/painwebinar

 


PROGRAM FACULTY

Christopher Gharibo, MD

Medical Director of Pain Medicine

NYU Langone Health

Associate Professor of Anesthesiology, Pain Medicine and Orthopedics

New York, NY

Susan Pendergrass, MSN, MEd, APRN, FNP-BC

Nurse Practitioner

Independent Pain Consultant

Fernandina Beach, FL

 

 

AANP DESIGNATION STATEMENT – This activity is approved for 3.0 contact hour(s) of continuing education (which includes 1.0 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 20054267. This activity was planned in accordance with AANP Accreditation Standards and Policies.

 

AAPA DESIGNATION STATEMENT – This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 3 AAPA Category 1 CME credits. Approval is valid from 6/15/2020 to 6/15/2021. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-200578.

 

FEE AND RECEIVING CME CREDIT - There is no fee for this activity. To receive credit, participants must register, view the live CME activity in its entirety, and then complete the post-test, with a score of 66% or better, and evaluation. The estimated time for completion of this activity is 1 hour. Participants are allowed to take the post-test multiple times.

 

Disclosures will be made known to participants before the activity.


Jointly provided by USF Health and Rockpointe

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).  

Event Agenda

Attachments